Summary of Significant Accounting Policies (Tables)
|
9 Months Ended |
Sep. 30, 2026 |
| Accounting Policies [Abstract] |
|
| Schedule of Cash and Cash Equivalents |
The following table provides a reconciliation of the Company’s cash, cash equivalents and restricted cash reported on the condensed consolidated balance sheets that sum to the total of the same such amount shown on the condensed consolidated statements of cash flows for the nine months ended September 30, 2026: | | | | | | | | | | | | | September 30, | | December 31, | | 2026 | | 2025 | | Cash, cash equivalents and restricted cash | | | | | Cash | $ | 25,435 | | | $ | 10,101 | | | Money market funds | 45,562 | | | 184,412 | | | Restricted cash - non-current | 1,000 | | | 1,000 | | | Total cash, cash equivalents and restricted cash | $ | 71,997 | | | $ | 195,513 | |
|
| Schedule of Restricted Cash |
The following table provides a reconciliation of the Company’s cash, cash equivalents and restricted cash reported on the condensed consolidated balance sheets that sum to the total of the same such amount shown on the condensed consolidated statements of cash flows for the nine months ended September 30, 2026: | | | | | | | | | | | | | September 30, | | December 31, | | 2026 | | 2025 | | Cash, cash equivalents and restricted cash | | | | | Cash | $ | 25,435 | | | $ | 10,101 | | | Money market funds | 45,562 | | | 184,412 | | | Restricted cash - non-current | 1,000 | | | 1,000 | | | Total cash, cash equivalents and restricted cash | $ | 71,997 | | | $ | 195,513 | |
|
| Schedule of Valuation and Qualifying Account Activity |
The activity in our allowance for credit losses for the nine months ended September 30, 2026 and 2025 is as follows: | | | | | | | | | | | | | 2026 | | 2025 | | Beginning balance for credit losses | $ | 257 | | | $ | 273 | | | Provision for (recoveries of) bad debt | 625 | | | (16) | | | Write-offs | (432) | | | — | | | Ending balance for credit losses | $ | 450 | | | $ | 257 | |
|
| Schedule of Components of Investments |
Investments consisted of the following as of September 30, 2026 and December 31, 2025: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of September 30, 2026 | | | Adjusted Cost Basis | | Unrealized Gains | | Unrealized Losses | | Fair Value | | Cash and Cash Equivalents | | Marketable Securities - Current | | Marketable Securities - Non-current | | Money market funds | | $ | 45,562 | | | $ | — | | | $ | — | | | $ | 45,562 | | | $ | 45,562 | | | $ | — | | | $ | — | | | Total investments | | $ | 45,562 | | | $ | — | | | $ | — | | | $ | 45,562 | | | $ | 45,562 | | | $ | — | | | $ | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2025 | | | | Adjusted Cost Basis | | Unrealized Gains | | Unrealized Losses | | Fair Value | | Cash and Cash Equivalents | | Marketable Securities - Current | | Marketable Securities - Non-current | | | Money market funds | | $ | 184,412 | | | $ | — | | | $ | — | | | $ | 184,412 | | | $ | 184,412 | | | $ | — | | | $ | — | | | | Total investments | | $ | 184,412 | | | $ | — | | | $ | — | | | $ | 184,412 | | | $ | 184,412 | | | $ | — | | | $ | — | | |
|
| Schedule of Interest (Expense) Income, Net |
Interest expense, net of interest income, consisted of the following for the three and nine months ended September 30, 2026 and 2025: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Interest expense, net of interest income | | | | | | | | | Interest expense | $ | (2,620) | | | $ | (3,815) | | | $ | (10,323) | | | $ | (11,416) | | | Interest income | 891 | | | 2,255 | | | 3,890 | | | 7,464 | | | Total interest expense, net of interest income | $ | (1,729) | | | $ | (1,560) | | | $ | (6,433) | | | $ | (3,952) | |
|